KA
ABMD

Kaizen Advisory’s Abiomed Inc ABMD Stock Holding History

Kaizen Advisory’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$36K Buy
112
+5
+5% +$1.74K 0.03% 390
2018
Q3 		$48K Sell
107
-4,173
-98% -$1.65M 0.03% 345
2018
Q2 		$1.75M Buy
4,280
+3,231
+308% +$1.17M 0.89% 5
2018
Q1 		$305K Buy
+1,049
New +$266K 0.3% 28

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Kaizen Advisory's ABMD Position: Q4 2018 in Review

Kaizen Advisory increased its Abiomed Inc (ABMD) stake by 4.7% in Q4 2018, buying an estimated $1.74K and bringing the position to 112 shares worth $36K. The position accounts for 0.03% of the portfolio, ranked #390.

Kaizen Advisory first reported a position in ABMD in Q1 2018 and has held it in 4 quarters since. The position peaked at $1.75M in Q2 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

  • Kaizen Advisory held 112 shares of Abiomed Inc worth $36K as of Q4 2018.
  • Kaizen Advisory bought 5 Abiomed Inc shares in Q4 2018, an estimated $1.74K.
  • Abiomed Inc made up 0.03% of Kaizen Advisory's portfolio in Q4 2018, its #390 holding.
  • Kaizen Advisory first reported a position in Abiomed Inc in Q1 2018 and has held it in 4 quarters since.
  • Kaizen Advisory's Abiomed Inc position peaked at $1.75M in Q2 2018.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Kaizen Advisory's 13F filing for Q4 2018, filed 15 Feb 2019.